Healthstream Dividend Insights: Key Information Ahead of Ex-Dividend Date Aug 18, 2025
Generated by AI AgentAinvest Dividend Digest
Thursday, Aug 14, 2025 10:17 pm ET1min read
HSTM--
Aime Summary
Recently, HealthStreamHSTM--, Inc. announced a dividend of $0.031 per share, with the ex-dividend date set for Aug 18, 2025, and the dividend payment scheduled for Aug 29, 2025. The announcement date was Aug 4, 2025. This dividend is a cash distribution and is consistent with the company's previous dividend on May 30, 2025, which was also $0.031 per share. Comparatively, this payout is lower than the average dividend of $0.116 per share over the last ten distributions, reflecting a consistent trend in the company's dividend strategy.
In the past week, HealthStream has faced several developments that could impact its market performance. As of late, the company's revenue reported for the second quarter of 2025 was slightly below analyst estimates but aligned with consensus expectations. This indicates potential hurdles in growth despite steady earnings projections. Analysts have indicated that earnings for HealthStream are expected to grow by 1.59% in the coming year, increasing from $0.63 to $0.64 per share, offering a cautious yet optimistic outlook on its financial health.
Additionally, over the past week, HealthStream's stock price has experienced a decline of 7.25% over the last year, currently trading around $26.34 per share. This downturn in stock value has prompted analysts to raise the target price to $28.00, signaling potential growth opportunities. Furthermore, recent technical analysis showed a narrowing of BollingerBINI-- Bands on the 15-minute chart, accompanied by a bearish Marubozu candle on Aug 11, 2025, suggesting potential short-term volatility in stock movement.
In conclusion, HealthStream is navigating a complex landscape with both challenges and opportunities ahead. Investors should note that Aug 18, 2025, marks the ex-dividend date, the last day to purchase shares and be eligible for the upcoming dividend. Any stock acquisition after this date will not qualify for the current dividend payout.
In the past week, HealthStream has faced several developments that could impact its market performance. As of late, the company's revenue reported for the second quarter of 2025 was slightly below analyst estimates but aligned with consensus expectations. This indicates potential hurdles in growth despite steady earnings projections. Analysts have indicated that earnings for HealthStream are expected to grow by 1.59% in the coming year, increasing from $0.63 to $0.64 per share, offering a cautious yet optimistic outlook on its financial health.
Additionally, over the past week, HealthStream's stock price has experienced a decline of 7.25% over the last year, currently trading around $26.34 per share. This downturn in stock value has prompted analysts to raise the target price to $28.00, signaling potential growth opportunities. Furthermore, recent technical analysis showed a narrowing of BollingerBINI-- Bands on the 15-minute chart, accompanied by a bearish Marubozu candle on Aug 11, 2025, suggesting potential short-term volatility in stock movement.
In conclusion, HealthStream is navigating a complex landscape with both challenges and opportunities ahead. Investors should note that Aug 18, 2025, marks the ex-dividend date, the last day to purchase shares and be eligible for the upcoming dividend. Any stock acquisition after this date will not qualify for the current dividend payout.
Sip from the stream of US stock dividends. Your income play.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet